Business
Prenetics Reports Record Q4 and FY 2025 Results: IM8 Achieves $120M ARR¹ in 12 Months, Revenue Surges 480% YoY
Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 millionIM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR MilestoneStrategic Transformation Completed with Divestitures and Focus on IM8 Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero DebtCompany to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at https://ir.prenet
About this update from Prenetics Global Limited
[{"type":"image","alt":"Prenetics Global Limited","displaySize":"","headline":null,"caption":"Prenetics Global Limited","className":"","disableSlideshowImg":false,"size":{"original":{"width":156,"height":29,"url":"https://media.zenfs.com/en/globenewswire.com/28cddcde45fd51107349fbcad1dc5db7"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/thbLdQ40xTitzWmh7Xbggg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIxMDtoPTM5O2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/28cddcde45fd51107349fbcad1dc5db7","width":156,"height":29}},"lazy":false},{"type":"list","items":[{"val":[{"type":"text","content":"Total Revenue Increased 480% to $92.4 million for Full Year 2025, Q4 Revenue reached $36.6 million","length":103,"tagName":"p"}]},{"val":[{"type":"text","content":"IM8 Reaches $10 Million in Monthly Revenue in December 2025, Achieving $120M ARR Milestone","length":90,"tagName":"p"}]},{"val":[{"type":"text","content":"Strategic Transformation Completed with Divestitures and Focus on IM8 ","length":69,"tagName":"p"}]},{"val":[{"type":"text","content":"Total Adjusted Liquidity2 of Approximately $171 Million Following Sale of Insighta Stake to Tencent, with Zero Debt","length":115,"tagName":"p"}]},{"val":[{"type":"text","content":"Company to Host Earnings Call on February 18, 2026, at 10:00 a.m. ET and latest investor deck can be found at https://ir.prenetics.com","length":134,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":511,"olType":false},{"type":"text","content":"NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading consumer health sciences company and parent of the IM8 premium health and longevity brand, today announced financial results for fourth quarter and full year ended December 31, 2025.","length":327,"tagName":"p"},{"type":"text","content":"The year 2025 marked a transformational milestone for Prenetics. Driven by the breakout performance of IM8, the Company delivered record financial results while completing a strategic transformation to streamline operations and focus on IM8. During the year and into 2026, Prenetics divested ACT Genomics in a transaction valued at up to approximately $72 million in cash (of which approximately $46 million are gross proceeds to Prenetics), sold the Europa distribution business for up to $13 million in all-stock consi...